ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Ascent Pharmaceuticals INC.

Official 2024 U.S. DOL Form 5500 summary for Ascent Pharmaceuticals INC. (Ascent Pharmaceuticals INC. 401(k) Plan · EIN 45-3542806 · PN 001): $11.08M net assets, 478 active participants, and $8.41 per $10,000 (8.41 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorAscent Pharmaceuticals INC.
Filing IdentifierAscent Pharmaceuticals INC. 401(k) Plan · EIN 45-3542806 · PN 001
Plan Category & State401(k) Defined Contribution (NY)
Asset-Size Peer Cohort$5M-$25M
Plan Net Assets (2024)$11.08M
Active Participants478
Direct Admin Fee Rate$8.41 per $10,000 (8.41 bps)
Cohort Peer Median$37.06 per $10,000 (37.06 bps)
Primary Recordkeeper / ProviderWilshire Advisors
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI